MoneyWorks4Me

Genpharmasec - Quaterly Results

12 Nov 2024 Evaluate
The sales declined to Rs. 57.70 millions for the September 2024 quarter as compared to Rs. 78.59 millions during the corresponding quarter last year.The Total revenue for the quarter ended September 2024 of  Rs. 9.97  millions  grew by 16516.67% from Rs. 0.06 millions.Operating profit for the quarter ended September 2024 rose to 11.15 millions as compared to 1.10 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 57.70 78.59 -26.58 110.73 138.23 -19.89 304.06 255.16 19.16
Other Income 8.58 1.52 464.47 14.36 2.64 443.94 7.18 1.00 618.00
PBIDT 11.15 1.10 913.64 19.23 2.44 688.11 8.78 3.58 145.25
Interest 0.41 0.65 -36.92 1.12 1.28 -12.50 3.95 0.56 605.36
PBDT 10.74 0.45 2286.67 18.11 1.16 1461.21 4.83 3.02 59.93
Depreciation 0.43 0.01 4200.00 0.48 0.08 500.00 0.17 0.20 -15.00
PBT 10.31 0.44 2243.18 17.63 1.08 1532.41 4.66 2.82 65.25
TAX 0.34 0.38 -10.53 1.77 0.76 132.89 4.20 -8.43 -149.82
Deferred Tax 0.34 0.38 -10.53 1.77 0.76 132.89 4.20 -8.43 -149.82
PAT 9.97 0.06 16516.67 15.86 0.32 4856.25 0.46 11.25 -95.91
Equity 553.72 276.86 100.00 553.72 276.86 100.00 553.72 276.86 100.00
PBIDTM(%) 19.32 1.40 1280.59 17.37 1.77 883.83 2.89 1.40 105.82
Peers